1-4 of 4
Thomas C. Shea, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy Of a Pharmacokinetics-Directed IV Busulfan (Bu), Plus Cyclophosphamide (Cy) and Etoposide (E) Preparative Regimen With Autologous Hematopoietic Stem Cell Transplantation For Lymphoma: Final Report Of a Multi-Center Phase 2 Study In North America

Christopher R. Flowers, MD, Michael Lill, M.D., Luciano J Costa, MD, PhD, Tsiporah B. Shore, William Vaughan, MD, Michael Craig, MD, Cesar O. Freytes, MD, Thomas C. Shea, M.D., Mitchell E. Horwitz, MD, Joseph W. Fay, MD, Shin Mineishi, MD, Damiano Rondelli, MD, James Mason, MD, Vijay Reddy, MD, PhD, Ira Braunschweig, MD, Weiyun Ai, MD, PhD, Elizabeth Armstrong, MS, Angela Smith, MS, PA, Cathy Zhao, PhD, Agnes Elekes, MD, Kazunobu Kato, MD, PhD, Edmund K. Waller, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 768.
https://doi.org/10.1182/blood.V122.21.768.768
Published: 2013
Journal Articles

Minimal Residual Disease (MRD) Status Following Induction Chemo-Immunotherapy Predicts Progression-Free Survival In Mantle Cell Lymphoma (MCL): CALGB 50403 (Alliance)

Noreen Fulton, B.S., Jeffrey Johnson, M.S., Lawrence D. Kaplan, M.D., Greg Koval, B.S., Greg Malnassy, B.S., Sin-Ho Jung, Ph.D., Steve Devine, M.D., Thomas C. Shea, M.D., John P. Leonard, M.D., Bruce D. Cheson, M.D., Wendy Stock, M.D.
Journal: Blood
Blood (2013) 122 (21): 3002.
https://doi.org/10.1182/blood.V122.21.3002.3002
Published: 2013
Journal Articles

A Multicenter Phase II Study Of Bendamustine In Combination With Rituximab In Older Patients With Previously Untreated Diffuse Large B-Cell Lymphoma

Steven I. Park, MD, Kristy L. Richards, MD PhD, Adam S. Asch, MD, Oludamilola Olajide, MBBS, Allison M. Deal, MS, Anastasia Ivanova, PhD, James G. Wall, MD, Anna L. Sobol, MD, Matthew C. Foster, MD, Hyman B. Muss, MD, Thomas C. Shea, M.D.
Journal: Blood
Blood (2013) 122 (21): 1791.
https://doi.org/10.1182/blood.V122.21.1791.1791
Published: 2013
Journal Articles

BCR Hyper-Responsiveness In B Cells From Patients With Chronic Gvhd Is Blocked With The Syk Inhibitor R406

Jessica L. Allen, PhD, Prasanthi V. Tata, MS, Jenna Wooten, PhD, Matthew S. Fore, Allison M. Deal, MS, Andrew Sharf, Todd Hoffert, Philip A. Roehrs, MD, Paul M. Armistead, MD, PhD, James Coghill, MD, William A. Wood, MD, MPH, Thomas C. Shea, M.D., Jonathan Serody, MD, Kristy L. Richards, MD PhD, Madan Jagasia, MBBS, MS, Stephanie J. Lee, MD, MPH, Krista Rowe, RN, MSN, David Rizzieri, MD, Mitchell E. Horwitz, MD, Nelson J. Chao, MD, Stefanie Sarantopoulos, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 910.
https://doi.org/10.1182/blood.V122.21.910.910
Published: 2013